Objectives

1. To be able to articulate and understanding of why Control- IQ is advanced hybrid closed loop therapy.

2. To be able to differentiate the between Basal - IQ and Control - IQ algorithms.

3. To gain and understanding of how both, Basal - IQ and Control - IQ post market research and outcomes help patients with decreasing adverse events, hypoglycemia and hyperglycemia. 

Faculty

Molly McElwee-Malloy, RN, CDE

Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options.  Faculty or planner conflicts of interest are resolved before the educational activity.

None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.